|
GOLIM4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.763090E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.507000E-01 |
| Normal-vs-Stage2 |
1.121410E-01 |
| Normal-vs-Stage3 |
1.76283999999693E-05 |
| Normal-vs-Stage4 |
2.12759999995704E-06 |
| Stage1-vs-Stage2 |
2.427400E-01 |
| Stage1-vs-Stage3 |
7.59320000000008E-05 |
| Stage1-vs-Stage4 |
3.51960000000151E-05 |
| Stage2-vs-Stage3 |
1.117000E-01 |
| Stage2-vs-Stage4 |
4.578200E-02 |
| Stage3-vs-Stage4 |
5.030400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.597700E-03 |
| Normal-vs-AfricanAmerican |
1.841810E-03 |
| Normal-vs-Asian |
5.420400E-01 |
| Caucasian-vs-AfricanAmerican |
1.107180E-01 |
| Caucasian-vs-Asian |
9.680600E-01 |
| AfricanAmerican-vs-Asian |
5.283800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.83740000000632E-05 |
| Normal-vs-Female |
4.454800E-01 |
| Male-vs-Female |
5.788800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.703600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.406100E-02 |
| Normal-vs-Age(61-80Yrs) |
5.982800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.122400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.375200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.588000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.984600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.319600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.203970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.967400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.082800E-01 |
| Normal-vs-Grade 2 |
3.193400E-01 |
| Normal-vs-Grade 3 |
1.989450E-04 |
| Normal-vs-Grade 4 |
1.89269999673058E-08 |
| Grade 1-vs-Grade 2 |
1.717710E-02 |
| Grade 1-vs-Grade 3 |
4.229600E-04 |
| Grade 1-vs-Grade 4 |
1.71459999998014E-06 |
| Grade 2-vs-Grade 3 |
1.624370E-03 |
| Grade 2-vs-Grade 4 |
4.25710000029333E-07 |
| Grade 3-vs-Grade 4 |
6.642400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.626200E-01 |
| Normal-vs-ccB subtype |
6.54399999966415E-07 |
| ccA subtype-vs-ccB subtype |
2.90629742494275E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.023400E-03 |
| Normal-vs-N1 |
4.753900E-04 |
| N0-vs-N1 |
7.509500E-02 |
|
|
